Xiidra

Xiidra

Generic: lifitegrast 5%

Xiidra
DOSAGE 1 gtt BID (12 hours apart)
GENERIC Lifitegrast ophthalmic solution 5%
SIZE 60 vial carton
INDICATIONS Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
MECHANISM OF ACTION LFA-1 Antagonist
MICROBIOLOGY Inhibits T-cell activation which prevents inflammation
CONTRAINDICATIONS & WARNINGS None
PEDIATRIC USE Safety and effectiveness in pediatric patients have not been established in patients under 17 years old
PREGNANCY Not established
NOTE